|
| 汇宇制药-W(688553)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-04-28 | 11406.68 | 26.93% | 42360.00 | 0.00 | 29113.54 | 68.73% | 追加承诺限售股份上市流通 | | 2024-10-28 | 1839.79 | 4.34% | 30953.32 | 11406.68 | 29113.54 | 68.73% | 首发原股东限售股份 | | 2023-10-26 | 190.80 | 0.45% | 29113.54 | 13246.46 | 28922.74 | 68.28% | 首发战略配售股份 | | 2022-10-26 | 23693.01 | 55.93% | 28922.74 | 13437.26 | 28922.74 | 68.28% | 首发原股东限售股份,首发战略配售股份 | | 2022-04-26 | 260.43 | 0.61% | 5229.72 | 37130.28 | 5229.72 | 12.35% | 首发机构配售股份 |
|